Lifelong learning and the plastic brain

19 Nov 2014

Our brains are plastic. They continually remould neural connections as we learn, experience and adapt. Now researchers are asking if new understanding of these processes can help us train our brains.

Read More

DIAL B for Boeing

18 Nov 2014

Duncan McFarlane, Professor of Industrial Information Engineering and head of the Distributed Information & Automation Laboratory (DIAL) at the University's Institute of Manufacturing (IfM), and members of his research team have been working with Boeing since 2005, finding intelligent solutions to some challenging industrial problems.

Read More

The man with a thousand brains

31 Oct 2014

Forty million people worldwide are living with Alzheimer’s and this is only set to increase. But tiny brains grown in culture could help scientists learn more about this mysterious disease – and test new drugs.

Read More

Travellers under open skies: writers, artists and gypsies

30 Oct 2014

In her new book Representations of the Gypsy in the Romantic Period, Sarah Houghton-Walker provides a fascinating insight into writers’ and artists’ portrayals of wanderers. Her study focuses on a period when gypsies’ fragile place in the landscape, and on the margins of society, came increasingly under threat.  

Read More

The ‘ultimate’ stem cell

29 Oct 2014

In the earliest moments of a mammal’s life, the developing ball of cells formed shortly after fertilisation ‘does as mother says’ – it follows a course that has been pre-programmed in the egg by the mother. Extraordinary as this is, what happens then is even more remarkable.

Read More

Return of the new gods: Jedis, auras and online witch schools

24 Oct 2014

Research by a digital anthropologist is looking at how new religious movements are harnessing online platforms. These ‘invented religions’ take inspiration from ancient philosophy and recent cultural events to develop doctrine and communities of believers in digital spaces.

Read More

Testing time for stem cells

23 Oct 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge’s expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic cells for drug screening.

Read More

Pages